Search

Your search keyword '"Endo, T."' showing total 7,112 results
Start Over Author "Endo, T."
7,112 results on '"Endo, T."'

51. P1212: PERSONALIZED TREATMENT FOR ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Author

Nukariya, H., primary, Miura, K., additional, Takahashi, H., additional, Nakagawa, M., additional, Hamada, T., additional, Itho, S., additional, Ichinohe, T., additional, Endo, T., additional, Kurihara, K., additional, Koike, T., additional, Iizuka, K., additional, Ohtake, S., additional, Yoshihito, U., additional, Iriyama, N., additional, Hatta, Y., additional, and Nakamura, H., additional

Published
2022
Full Text
View/download PDF

55. High-Resolution Gamma-Spectroscopy of Λ 7Li and Λ 9Be

Author

Tamura, H., Abe, D., Ajimura, S., Akikawa, H., Araki, K., Bhang, H. C., Chrien, R. E., Endo, T., Eugenio, P., Franklin, G. B., Fujii, Y., Fukuda, T., Gan, L., Hashimoto, O., Hotchi, H., Imai, K., Kakiguchi, Y., Khaustov, P., Kim, J. H., Kim, Y. D., Kohri, H., May, M., Miyoshi, T., Murakami, T., Nagae, T., Nakano, J., Noumi, H., Outa, H., Ozawa, K., Pile, P. H., Quinn, B. P., Rusek, A., Saito, T., Sasao, J., Sato, Y., Satoh, S., Sawafta, R. I., Schumacher, R. A., Sekimoto, M., Takahashi, T., Tamagawa, T., Tang, L., Tanida, K., Xia, H. H., Yuan, L., Zhou, S. H., Zhu, L. H., Zhu, X. F., Plessas, W., editor, Oryu, Shinsho, editor, Kamimura, Masayasu, editor, and Ishikawa, Souichi, editor

Published
2000
Full Text
View/download PDF

60. Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor

Author

Saito T, Ishioka S, Kiya T, Honnma H, Kuno Y, Morishita M, Shimizu A, Ikeda K, Endo T, and Baba T

Subjects
Gynecology and obstetrics, RG1-991
Abstract

Tsuyoshi Baba,1 Toshiaki Endo,1 Keiko Ikeda,1 Ayumi Shimizu,1 Miyuki Morishita,1 Yoshika Kuno,1 Hiroyuki Honnma,2 Tamotsu Kiya,3 Shin-ichi Ishioka,1 Tsuyoshi Saito11Department of Obstetrics and Gynecology, Sapporo Medical University, Sapporo, 2Asada Ladies Clinic, Kasugai, Aichi, 3Ena Ladies Clinic, Ishikari, Hokkaido, JapanAbstract: This report presents an unusual case of Sertoli-stromal cell tumor and polycystic ovary syndrome successfully treated with weight reduction and an insulin-sensitizing agent. A 22-year-old woman, gravida 0, para 0, visited our hospital for the first time with a 12-year history of secondary amenorrhea and hypertrichosis. Transvaginal ultrasonography revealed a solid tumor in the right ovary. Right salpingo-oophorectomy was performed and pathological examination confirmed a Sertoli-stromal cell tumor. The patient's serum androgen levels declined postoperatively, but remained above normal. Pioglitazone treatment for 6 months also significantly reduced serum androgen levels, but they still remained above normal. However, after losing 12 kg of body weight, the patient's serum androgen levels declined to normal, and spontaneous menstruation became regular. Weight reduction with pioglitazone is an effective means of treating hyperandrogenism.Keywords: etiology, hyperandrogenism, pioglitazone, polycystic ovary syndrome, Sertoli-stromal cell tumor, weight reduction

Published
2012

61. 64P Clinical benefit of platinum doublet therapy for elderly patients with advanced non-small cell lung cancer: A prospective multicenter study of the national hospital organization in Japan

Author

Shimokawa, M., primary, Kanazu, M., additional, Saito, R., additional, Mori, M., additional, Tamura, A., additional, Okano, Y., additional, Fujita, Y., additional, Endo, T., additional, Motegi, M., additional, Takata, S., additional, Kita, T., additional, Sukoh, N., additional, Takenoyama, M., additional, and Atagi, S., additional

Published
2022
Full Text
View/download PDF

65. I. ANNUAL SUMMARY OF EXPERIMENTAL RESEARCH ACTIVITIES. I-1. PROJECT RESEARCHES

Author

Pyeon, C. H., Yamanaka, M., Hashimoto, K., Aizawa, N., Ohizumi, A., Fukushima, M., Chiba, G., Watanabe, K., and Endo, T.

Abstract

PR2-1 Subcriticality Monitoring for a Reactor System Driven by Spallation Source (III) /K. Hashimoto et al.(31P2-1) [12], PR2-2 Measurement of Reaction Rates of Intermediate Neutrons on Accelerator-Driven System with Spallation Neutrons /N. Aizawa et al.(31P2-2) [13], PR2-3 Measurement of 243Am Fission Rates in Low-Enriched Uranium Region at A-core of KUCA /A. Oizumi et al.(31P2-3) [14], PR2-4 Development of Real-time Subcriticality Monitor /K. Watanabe et al.(31P2-5) [15], In case that corrections are made, an errata will be provided in the following webpage: https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2019/ProgRep2019.html

Published
2020

66. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

Author

Li Bassi, G., Gibbons, K., Suen, J. Y., Dalton, H. J., White, N., Corley, A., Shrapnel, S., Hinton, S., Forsyth, S., Laffey, J. G., Fan, E., Fanning, J. P., Panigada, M., Bartlett, R., Brodie, D., Burrell, A., Chiumello, D., Elhazmi, A., Esperatti, M., Grasselli, G., Hodgson, C., Ichiba, S., Luna, C., Marwali, E., Merson, L., Murthy, S., Nichol, A., Ogino, M., Pelosi, P., Torres, A., P. Y., Ng, Fraser, J. F., Al-Dabbous, T., Alfoudri, H., Shamsah, M., Elapavaluru, S., Berg, A., Horn, C., Mayasi, Y., Schroll, S., Meyer, D., Velazco, J., Ploskanych, L., Fikes, W., Bagewadi, R., Dao, M., White, H., Ehlers, A., Shalabi-McGuire, M., Witt, T., Grazioli, L., Lorini, L., Grandin, E. W., Nunez, J., Reyes, T., Obriain, D., Hunter, S., Ramanan, M., Affleck, J., Veerendra, H. H., Rai, S., Russell-Brown, J., Nourse, M., Joseph, M., Mitchell, B., Tenzer, M., Abe, R., Cho, H. J., Jeong, I. S., Rahman, N., Kakar, V., Brozzi, N., Mehkri, O., Krishnan, S., Duggal, A., Houltham, S., Graf, J., Diaz, R., Orrego, R., Delgado, C., Gonzalez, J., Sanchez, M. S., Piagnerelli, M., Sarrazin, J. V., Zabert, A. /P. G., Espinosa, L., Delgado, P., Delgado, V., Rincon, D. F. B., Yanten, A. M. M., Duque, M. B., Al-Hudaib, A., Callahan, M., Taufik, M. A., Wardoyo, E. Y., Gunawan, M., Trisnaningrum, N. S., Irawany, V., Rayhan, M., Pesenti, A., Zanella, A., Leone, M., Coppola, S., Colombo, S., Antonelli, M., Carelli, S., Grieco, D. L., Asaki, M., Hoshino, K., Salazar, L., Duarte, L., Laffey, J., Mcnicholas, B., Cosgrave, D., Mccaffrey, J., Bone, A., Hakeem, Y., Winearls, J., Tallott, M., Thomson, D., Arnold-Day, C., Cupido, J., Fanie, Z., Miller, M., Seymore, L., van Straaten, D., Hssain, A. A., Aliudin, J., Alqahtani, A. -R., Mohamed, K., Mohamed, A., Tan, D., Villanueva, J., Zaqout, A., Kurtzman, E., Ademi, A., Dobrita, A., El Aoudi, K., Segura, J., Giwangkancana, G., Ohshimo, S., Hitoshi, S., Osatnik, J., Joosten, A., Yang, M., Motos, A., Arancibia, F., Williams, V., Noel, A., Luque, N., Trung, T. H., Yacoub, S., Fantini, M., Garcia, R. N. J., Alvarez, E. C., Greti, A., Ceccato, A., Sanchez, A., Vazquez, A. L., Roche-Campo, F., Franch-Llasat, D., Tuazon, D., Amato, M., Cassimiro, L., Pola, F., Ribeiro, F., Fonseca, G., Dalton, H., Desai, M., Osborn, E., Deeb, H., Arcadipane, A., Martucci, G., Panarello, G., Vitiello, C., Bianco, C., Occhipinti, G., Rossetti, M., Cuffaro, R., Cho, S. -M., Shimizu, H., Moriyama, N., Kim, J. -B., Kitamura, N., Gebauer, J., Yokoyama, T., Al-Fares, A., Buabbas, S., Alamad, E., Alawadhi, F., Alawadi, K., Tanaka, H., Hashimoto, S., Yamazaki, M., T. -H., Oh, Epler, M., Forney, C., Kruse, L., Feister, J., Williamson, J., Grobengieser, K., Gnall, E., Golden, S., Caroline, M., Shapiro, T., Karaj, C., Thome, L., Sher, L., Vanderland, M., Welch, M., Mcdermott, S., Brain, M., Mineall, S., Kimura, D., Brazzi, L., Sales, G., Ogston, T., Nagpal, D., Fischer, K., Lorusso, R., Rangappa, R., Appu, A., Carton, E. G., Sen, A., Palacios, A., Rainey, D., Samoukoviv, G., Campisi, J., Durham, L., Neumann, E., Seefeldt, C., Falcucci, O., Emmrich, A., Guy, J., Johns, C., Potzner, K., Zimmermann, C., Espinal, A., Buchtele, N., Schwameis, M., Stecher, S. -S., Singh, D., Barnikel, M., Arenz, L., Zaaqoq, A., Galloway, L. A., Merley, C., Csete, M., Quesada, L., Saba, I., Kasugai, D., Hiraiwa, H., Tanaka, T., Purnama, Y., Dewayanti, S. R., Ardiyan, Juzar, D. A., Siagian, D., Chen, Y. -S., Ratsep, I., Oigus, G., Erikson, K., Post, A. -M., Enneveer, L., Sillaots, P., Manetta, F., Mihelis, E., Sarmiento, I. C., Narasimhan, M., Varrone, M., Komats, M., Garcia-Diaz, J., Harmon, C., Satyapriya, S. V., Bhatt, A., Mokadam, N. A., Uribe, A., Gonzalez, A., Shi, H., Mckeown, J., Pasek, J., Fiorda, J., Echeverria, M., Moreno, R., Zakhary, B., Cavana, M., Cucino, A., Foti, G., Giani, M., Russotto, V., Castagna, V., Dellamore, A., Navalesi, P., Shum, H. -P., Vuysteke, A., Usman, A., Acker, A., Smood, B., Mergler, B., Sertic, F., Subramanian, M., Sperry, A., Rizer, N., Burhan, E., Rasmin, M., Akmal, E., Sitompul, F., Lolong, N., Naivedh, B., Erickson, S., Barrett, P., Dean, D., Daugherty, J., Loforte, A., Khan, I., Abraar Quraishi, M., Desantis, O., So, D., Kandamby, D., Mandei, J. M., Natanael, H., Yudhalantang, E., Lantang, A., Wijaya, S. O., Jung, A., Ng, G., W. Y., Ng, Fang, S., Tabah, A., Ratcliffe, M., Duroux, M., Adachi, S., Nakao, S., Blanco, P., Prieto, A., Sanchez, J., Nicholson, M., Butt, W., Serratore, A., Delzoppo, C., Janin, P., Yarad, E., Totaro, R., Coles, J., Pujo, B., Balk, R., Vissing, A., Kapania, E., Hays, J., Fox, S., Yantosh, G., Mishin, P., Yuliarto, S., Hari Santoso, K., Djajalaksana, S., Fatoni, A. Z., Fukuda, M., Liu, K., Battaglini, D., Jimenez, J. F. M., Bastos, D., Gaiao, S., Rusmawatiningtyas, D., Buchner, J., Cho, Y. -J., Lee, S. H., Kawasaki, T., Munshi, L., Sakiyalak, P., Nitayavardhana, P., Seitz, T., Arora, R., Kent, D., Marino, D., Parwar, S., Cheng, A., Miller, J., Fujitani, S., Shimizu, N., Madhok, J., Owyang, C., Buscher, H., Reynolds, C., Maasikas, O., Beljantsev, A., Mihnovits, V., Akimoto, T., Aizawa, M., Horibe, K., Onodera, R., Young, M., George, T., Shekar, K., Mcguinness, N., Irvine, L., Flynn, B., Endo, T., Sugiyama, K., Shimizu, K., Exconde, K., Lussier, L., Lotz, G., Malfertheiner, M., Maier, L., Dreier, E., Kusumastuti, N. P., Mccloskey, C., Dabaliz, A. -A., Elshazly, T. B., Smith, J., Szuldrzynski, K. S., Bielanski, P., Wille, K., Parhar, K. K. S., Fiest, K. M., Codan, C., Shahid, A., Fayed, M., Evans, T., Garcia, R., Gutierrez, A., Song, T., Rose, R., Bennett, S., Richardson, D., Peek, G., Arora, L., Rappapport, K., Rudolph, K., Sibenaller, Z., Stout, L., Walter, A., Herr, D., Vedadi, N., Thompson, S., Sindt, L., Rajnic, S., Ewald, C., Hoffman, J., Ying, X., Kennedy, R., Griffee, M., Ciullo, A., Kida, Y., Roca, R. F., Riera, J. I., Contreras, S., Alegre, C., Kay, C., Fischer, I., Renner, E., Taniguci, H., Fraser, J., Bassi, G. L., Suen, J., Barnett, A., Pearse, I., Abbate, G., Hassan, H., Heinsar, S., Karnik, V. A., Ki, K., Oneill, H. F., Obonyo, N., Pimenta, L. P., Reid, J. D., Sato, K., Vuorinen, A., Wildi, K. S., Wood, E. S., Yerkovich, S., Lee, J., Plotkin, D., Citarella, B. W., Hartley, E., Lubis, B., Ikeyama, T., Bhaskar, B., Jung, J. -S., Mcguinness, S., Eastwood, G., Marta, S. R., Guarracino, F., Gerle, S., Coxon, E., Claro, B., Loverde, D., Patil, N., Parrini, V., Mcbride, A., Negaard, K., Ratsch, A., Abdelaziz, A., Uribe, J. D., Peris, A., Sanders, M., Emerson, D., Kamal, M., Povoa, P., Francis, R., Cherif, A., Joseph, S., Di Nardo, M., Heard, M., Kyle, K., Blackwell, R. A., Biston, P., Jeong, H. W., Smith, R., Prawira, Y., Montrucchio, G., Garcia, A. H., Salterain, N., Meyns, B., Moreno, M., Walia, R., Mehta, A., Schweda, A., Supriatna, M., Kirakli, C., Williams, M., Kim, K. H., Assad, A., Giraldo, E., Karolak, W., Balik, M., Pocock, E., Gajkowski, E., Masafumi, K., Barrett, N., Takeyama, Y., Park, S., Amin, F., Andriyani, F. M., Sudakevych, S., Vera, M., Cornejo, R., Schwarz, P., Mardini, A. C., de Paula, T., Neto, A. S., Villoldo, A., Colafranceschi, A. S., Iglesias, A. U., Granjean, J., Melro, L. M. G., Romualdo, G. F., Gaia, D., Souza, H., Galas, F., Mendiluce, R. M., Sosa, A., Martinez, I., Kurosawa, H., Salgado, J., Hugi-MayrCharbonneau, B. E., Barzilai, V. S., Monteiro, V., de Souza, R. R., Harper, M., Suzuki, H., Adams, C., Brieva, J., Nyale, G., Eltatar, F. S., Fatani, J., Baeissa, H., Masri, A. A., Rabie, A., Hui, M. Y., Yamane, M., Jung, H., Margaret, A. M., Nacpil, N., Ruck, K., Bakken, R., Jara, C., Felton, T., Berra, L., Shah, B., Chakraborty, A., Cardona, M., Capatos, G., Akkanti, B., Orija, A., Jain, H., Ito, A., Housni, B., Low, S., Iihara, K., Chavez, J., Ramanathan, K., Zabert, G., Naidoo, K., Seppelt, I., Vandyk, M., Macdonald, S., Mcgregor, R., Siebenaler, T., Flynn, H., Lofton, K., Aokage, T., Shigemitsu, K., Moscatelli, A., Fiorentino, G., Baumgaertel, M., Mba, S. E., Assy, J., Hutahaean, A., Roush, H., Sichting, K. A., Alessandri, F., Burns, D., Salt, G., Garabedian, C. P., Millar, J., Sim, M., Mattke, A., Mcauley, D., Tadili, J., Frenzel, T., Bar-Lavie, Y., Ortiz, A. B., Stone, J., Attokaran, A., Farquharson, M., Patel, B., Gunning, D., Baillie, K., Watson, P., Tamai, K., Sajinadiyasa, G. K., Kanyawati, D., Salgado, M., Sassine, A., Yudo, B., Mccaul, S., Lee, B., Lee, S. M., Afek, A., Iwashita, Y., Semedi, B. P., Metiva, J., Van Belle, N., Martin-Loeches, I., Ivatt, L., Woon, C. Y., Kang, H. M., Smith, T., James, E., Al-Rawas, N., Iwasaki, Y., King-Chung, K. C., Gudzenko, V., Hugi-Mayr, B., Taccone, F., Perdhana, F., Lamarche, Y., Ribeiro, J. M., Bradic, N., Van den Bossche, K., Lansink, O., Singh, G., Debeuckelaere, G., Stelfox, H. T., Yi, C., Elia, J., Tribble, T., Shankar, S., Padmanabhan, R., Hallinan, B., Paoletti, L., Leyva, Y., Fykuda, T., Badulak, J., Koch, J., Hackman, A., Janowaik, L., Hernandez, D., Osofsky, J., Donadello, K., Lawang, A., Fine, J., Davidson, B., Vazquez, A. O. R., COVID-19 Critical Care Consortium, and Consortium, COVID-19 Critical Care

Subjects
Male, Respiratory Distress Syndrome, COVID-19, Intensive care unit, Mechanical ventilation, Neuromuscular blocking agent, SARS-CoV-2, Aged, Female, Humans, Intensive Care Units, Middle Aged, Propensity Score, Respiration, Artificial, Neuromuscular Blocking Agents, Respiration, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Settore MED/41 - Anestesiologia, Critical Care and Intensive Care Medicine, COVID-19 Drug Treatment, Artificial, Human medicine
Abstract

Background The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS) matching analysis. Methods We analyzed a convenience sample of patients with COVID-19 and moderate-to-severe ARDS, admitted to 244 intensive care units within the COVID-19 Critical Care Consortium, from February 1, 2020, through October 31, 2021. Patients undergoing at least 2 days and up to 3 consecutive days of NMBAs (NMBA treatment), within 48 h from commencement of IMV were compared with subjects who did not receive NMBAs or only upon commencement of IMV (control). The primary objective in the PS-matched cohort was comparison between groups in 90-day in-hospital mortality, assessed through Cox proportional hazard modeling. Secondary objectives were comparisons in the numbers of ventilator-free days (VFD) between day 1 and day 28 and between day 1 and 90 through competing risk regression. Results Data from 1953 patients were included. After propensity score matching, 210 cases from each group were well matched. In the PS-matched cohort, mean (± SD) age was 60.3 ± 13.2 years and 296 (70.5%) were male and the most common comorbidities were hypertension (56.9%), obesity (41.1%), and diabetes (30.0%). The unadjusted hazard ratio (HR) for death at 90 days in the NMBA treatment vs control group was 1.12 (95% CI 0.79, 1.59, p = 0.534). After adjustment for smoking habit and critical therapeutic covariates, the HR was 1.07 (95% CI 0.72, 1.61, p = 0.729). At 28 days, VFD were 16 (IQR 0–25) and 25 (IQR 7–26) in the NMBA treatment and control groups, respectively (sub-hazard ratio 0.82, 95% CI 0.67, 1.00, p = 0.055). At 90 days, VFD were 77 (IQR 0–87) and 87 (IQR 0–88) (sub-hazard ratio 0.86 (95% CI 0.69, 1.07; p = 0.177). Conclusions In patients with COVID-19 and moderate-to-severe ARDS, short course of NMBA treatment, applied early, did not significantly improve 90-day mortality and VFD. In the absence of definitive data from clinical trials, NMBAs should be indicated cautiously in this setting.

Published
2022
Full Text
View/download PDF

67. Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome

Author

Morishita M, Shimizu A, Ikeda K, Kitajima Y, Baba T, Kanaya M, Honnma H, Endo T, and Saito T

Subjects
Gynecology and obstetrics, RG1-991
Abstract

Mika Kanaya,1 Tsuyoshi Baba,2 Yoshimitsu Kitajima,2 Keiko Ikeda,2 Ayumi Shimizu,2 Miyuki Morishita,2 Hiroyuki Honnma,3 Toshiaki Endo,2 Tsuyoshi Saito21Mika Ladies Clinic, 2Department of Obstetrics and Gynecology, Sapporo Medical University, School of Medicine, 3Kamiya Ladies Clinic, Sapporo, JapanContext: Follicle-stimulating hormone (FSH)-secreting pituitary adenoma is usually a nonfunctioning tumor, but in rare cases it may develop into ovarian hyperstimulation. Several reports have revealed that serum FSH levels are normal to slightly high in patients with combined FSH-secreting pituitary adenoma with ovarian hyperstimulation. This finding is different from iatrogenic ovarian hyperstimulation syndrome (OHSS), which is associated with extremely high levels of FSH.Objective: To describe the clinical course of two patients who developed OHSS from FSH-secreting pituitary adenoma.Results: Endocrine studies of the two cases revealed that FSH levels were normal or slightly increased, but luteinizing hormone levels were low to undetectable. Their estradiol (E2) levels were intriguing: levels fluctuated drastically over 6 weeks in Case 1, but stayed flat in Case 2. Ultrasonographic examinations showed bilaterally enlarged multicystic ovaries, and magnetic resonance imaging indicated pituitary tumors. Transsephenoidal resection of the tumors ameliorated the symptoms and pathological diagnosis revealed FSH-secreting pituitary adenomas.Conclusion: As is not the case in iatrogenic OHSS, even a small to moderate amount of FSH stimulation, which is continuously secreted by a pituitary adenoma, can cause ovarian hyperstimulation. Although FSH-secreting pituitary adenoma can cause ovarian hyperstimulation, an extremely high amount of E2 biosynthesis from granulosa cells seldom occurs.Keywords: pituitary adenoma, OHSS, FSH, estradiol, luteinizing hormone

Published
2012

78. Roaming in Formaldehyde – and how to get there

Author

Endo, T., primary, Neville, S.P., additional, Lassonde, P., additional, Qu, C., additional, Fujise, H., additional, Fushitani, M., additional, Hishikawa, A., additional, Houston, P.L., additional, Bowman, J.M., additional, Légaré, F., additional, Schuurman, M.S., additional, and Ibrahim, H., additional

Published
2022
Full Text
View/download PDF

79. Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

Author

Matoba, Tetsuya, primary, Yasuda, Satoshi, additional, Kaikita, Koichi, additional, Akao, Masaharu, additional, Ako, Junya, additional, Nakamura, Masato, additional, Miyauchi, Katsumi, additional, Hagiwara, Nobuhisa, additional, Kimura, Kazuo, additional, Hirayama, Atsushi, additional, Matsui, Kunihiko, additional, Ogawa, Hisao, additional, Matoba, Tetsuya, additional, Koretsune, Yukihiro, additional, Hiro, Takafumi, additional, Sumiyoshi, Tetsuya, additional, Kimura, Kazumi, additional, Hashimoto, Yoichiro, additional, Hirano, Teruyuki, additional, Daida, Hiroyuki, additional, Okada, Yasushi, additional, Yamazaki, Tsutomu, additional, Nakamura, A., additional, Tamiya, E., additional, Yamamoto, T., additional, Suetake, S., additional, Noguchi, T., additional, Nakamura, S., additional, Matsumura, A., additional, Kojima, J., additional, Suwa, S., additional, Yamaguchi, H., additional, Kaikita, K., additional, Yasu, T., additional, Nakajima, A., additional, Yamada, T., additional, Arai, H., additional, Hata, Y., additional, Sakanashi, T., additional, Tateishi, H., additional, Nakayama, T., additional, Nozaki, Y., additional, Akao, M., additional, Okumura, Y., additional, Tokue, M., additional, Kuroki, N., additional, Maruyama, Y., additional, Matoba, T., additional, Hagiwara, N., additional, Suzuki, H., additional, Nishida, Y., additional, Ajioka, M., additional, Yumoto, K., additional, Shimizu, S., additional, Aoyama, T., additional, Shimomura, H., additional, Takeda, T., additional, Oshiro, K., additional, Sugishita, N., additional, Shibata, Y., additional, Otonari, T., additional, Kihara, H., additional, Ogawa, H., additional, Ohno, A., additional, Hazama, M., additional, Shimizu, M., additional, Tsukahara, K., additional, Haruta, S., additional, Wakeyama, T., additional, Haruna, T., additional, Ito, M., additional, Fujii, K., additional, Atsuchi, N., additional, Sata, M., additional, Kimura, K., additional, Hasebe, N., additional, Kobayasi, Y., additional, Ohsato, K., additional, Hironaga, K., additional, Naganuma, Y., additional, Anzaki, K., additional, Oiwa, K., additional, Okazaki, S., additional, Nakagawa, Y., additional, Tokuhiro, K., additional, Tanaka, K., additional, Momose, T., additional, Fukushima, Y., additional, Kametani, R., additional, Kawamitsu, K., additional, Saito, Y., additional, Akashi, S., additional, Kumagai, K., additional, Eshima, K., additional, Tobaru, T., additional, Seo, T., additional, Okuhara, K., additional, Kozuma, K., additional, Ikari, Y., additional, Takahashi, T., additional, Michishita, I., additional, Fujikura, H., additional, Momomura, S., additional, Yamamoto, Y., additional, Otomo, K., additional, Matsubara, T., additional, Tashiro, H., additional, Inoue, T., additional, Ishihara, M., additional, Shiojima, I., additional, Tachibana, E., additional, Ako, J., additional, Sumii, K., additional, Yamamoto, N., additional, Ohmura, N., additional, Nakamura, T., additional, Morita, Y., additional, Takahashi, N., additional, Watanabe, K., additional, Fujinaga, H., additional, Maruyama, M., additional, Oka, T., additional, Shirayama, T., additional, Amano, T., additional, Fukui, K., additional, Ando, K., additional, Oshima, S., additional, Kagiyama, S., additional, Teragawa, H., additional, Yuge, M., additional, Ono, S., additional, Koga, T., additional, Fujiu, K., additional, Kuwabara, M., additional, Ohya, Y., additional, Yumoto, Y., additional, Kuji, N., additional, Ikemura, M., additional, Kario, K., additional, Chatani, K., additional, Sato, K., additional, Miyagi, H., additional, Murakami, M., additional, Saito, K., additional, Hoshiga, M., additional, Sato, S., additional, Kubo, N., additional, Sakamoto, Y., additional, Ashida, K., additional, Sakamoto, H., additional, Murasaki, S., additional, Uehara, H., additional, Akasaka, T., additional, Ooba, Y., additional, Nakahara, S., additional, Hanaoka, Y., additional, Nishimiya, T., additional, Tsunoda, R., additional, Onuma, Y., additional, Higuchi, S., additional, Tani, A., additional, Wada, A., additional, Kato, M., additional, Obata, H., additional, Higuchi, Y., additional, Endo, T., additional, Katou, R., additional, Matsunaga, T., additional, Matsuoka, T., additional, Noguchi, H., additional, Usui, M., additional, Hayashi, T., additional, Otsuji, Y., additional, Osaki, T., additional, Zaizen, H., additional, Yoshihara, H., additional, Kadota, K., additional, Hirose, T., additional, Miyazawa, T., additional, Mori, A., additional, Takano, M., additional, Shimizu, W., additional, Wake, M., additional, Oriso, S., additional, Yoshiyama, M., additional, Kakinoki, S., additional, Nishioka, T., additional, Ozaki, T., additional, Nomoto, K., additional, Seki, K., additional, Kawai, K., additional, Ozaki, Y., additional, Miura, S., additional, Kawasaki, M., additional, Funada, R., additional, Dote, K., additional, Nagano, T., additional, Okamoto, S., additional, Kubo, T., additional, Murozono, Y., additional, Owada, T., additional, Doke, T., additional, Matsumura, T., additional, Horiuchi, M., additional, Takaishi, A., additional, Yamamoto, M., additional, Nakashima, H., additional, Munemasa, M., additional, Sakata, Y., additional, Inoue, N., additional, Ota, T., additional, Hamano, Y., additional, Abe, N., additional, Tsubokura, T., additional, Goto, M., additional, Kubota, I., additional, Yano, M., additional, Umetani, K., additional, Date, T., additional, Morimoto, H., additional, Noda, T., additional, Goto, S., additional, Hibi, K., additional, Nakano, A., additional, Hiramitsu, S., additional, Kihara, Y., additional, Sugi, M., additional, Shiba, N., additional, Izumi, D., additional, Sato, T., additional, Tayama, S., additional, Matsui, T., additional, Suzuki, A., additional, Ajiki, K., additional, Oishi, M., additional, Kiryu, M., additional, Ko, T., additional, Ando, H., additional, Miyazaki, S., additional, Kinugawa, T., additional, Otake, H., additional, Kitaoka, H., additional, Hirata, Y., additional, Honda, S., additional, Manita, M., additional, Ishii, Y., additional, Oka, H., additional, Nanba, Y., additional, Nishino, M., additional, Sakamoto, T., additional, Saito, T., additional, Sakai, H., additional, Ichikawa, M., additional, Namiuchi, S., additional, Inoue, K., additional, Komiyama, N., additional, Akashi, Y., additional, Nakamura, Y., additional, Komaru, T., additional, Hosokawa, T., additional, Chikamori, T., additional, Tanaka, H., additional, Arasaki, O., additional, Aonuma, K., additional, Wakasa, Y., additional, Yoshizawa, T., additional, Sugano, T., additional, Yokota, N., additional, Kakutani, A., additional, Suzuki, T., additional, Abe, Y., additional, Kataoka, T., additional, Okayama, H., additional, Yokoi, H., additional, Chin, K., additional, Hasegawa, K., additional, Tomita, H., additional, Honzyo, H., additional, Kawai, H., additional, Yamamoto, K., additional, Morino, Y., additional, Tsujiyama, S., additional, Hamasaki, S., additional, Niijima, Y., additional, Mizuno, Y., additional, Maki, A., additional, Tanabe, K., additional, Murohara, T., additional, Naomi, S., additional, Arikawa, M., additional, Kato, T., additional, Matsumoto, N., additional, Minamino, T., additional, Sairenji, H., additional, Miyamoto, N., additional, Ito, H., additional, Matsuura, Y., additional, Hata, S., additional, Nakatsu, Y., additional, Onodera, T., additional, Yoshimura, M., additional, Amano, H., additional, Tokutake, E., additional, Kasao, M., additional, Moriguchi, M., additional, Tsuji, M., additional, Yamamoto, H., additional, Yanbe, Y., additional, Iwasawa, T., additional, Suzuki, M., additional, and Mori, H., additional

Published
2021
Full Text
View/download PDF

84. Laser Fusion — High Density Compression Experiment and Ignition Program with Gekko XII

Author

Nakai, S., Mima, K., Azechi, H., Miyanaga, N., Nishiguchi, A., Yamanaka, T., Nishihara, K., Tanaka, K. A., Nakai, M., Kodama, R., Katayama, M., Kado, M., Tsukamoto, M., Kato, Y., Takabe, H., Nishimura, H., Shiraga, H., Endo, T., Nakatsuka, M., Sasaki, T., Jitsuno, T., Yoshida, K., Kanabe, T., Nakano, H., Tsubakimoto, K., Yamanaka, M., Naito, K., Norimatsu, T., Takagi, M., Chen, T., Izawa, Y., Yamanaka, C., Miley, George H., editor, and Hora, Heinrich, editor

Published
1992
Full Text
View/download PDF

89. High Density Compression of Hollow-Shell Target by Gekko XII and Laser Fusion Research at Ile, Osaka University

Author

Nakai, S., Mima, K., Yamanaka, M., Azechi, H., Miyanaga, N., Nishiguchi, A., Nakaishi, H., Chen, Y.-W., Setsuhara, Y., Norreys, P. A., Yamanaka, T., Nishihara, K., Tanaka, K. A., Nakai, M., Kodama, R., Katayama, M., Kato, Y., Takabe, H., Nishimura, H., Shiraga, H., Endo, T., Kondo, K., Nakatsuka, M., Sasaki, T., Jitsuno, T., Yoshida, K., Kanabe, T., Yokotani, A., Norimatsu, T., Takagi, M., Katayama, H., Izawa, Y., Yamanaka, C., Hora, Heinrich, editor, and Miley, George H., editor

Published
1991
Full Text
View/download PDF

93. I. ANNUAL SUMMARY OF EXPERIMENTAL RESEARCH ACTIVITIES. I-1. PROJECT RESEARCHES

Author

Pyeon, C. H., Yamanaka, M., Hashimoto, K., Aizawa, N., Ohizumi, A., Fukushima, M., Chiba, G., Watanabe, K., and Endo, T.

Abstract

PR4-1 Subcriticality Monitoring for a Reactor System Driven by Spallation Source(II) /K. Hashimoto et al.(30P4-1) [36], PR4-2 Reaction Rate of Accelerator-Driven System with Spallation Neutrons /N. Aizawa et al.(30P4-2) [37], PR4-3 Measurement of MA Reaction Rates under Sub-Critical Condition with Spallation Neutron Source in A-Core of KUCA for ADS /A. Oizumi et al.(30P4-3) [38], PR4-4 Development of Real-Time Subcriticality Monitor /K. Watanabe et al.(30P4-5) [39], In case that corrections are made, an errata will be provided in the following webpage: https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2018/ProgRep2018.html

Published
2019

97. Search for Host Factors That Predict the Therapeutic Effect of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF)

Author

Arai, N., primary, Matsuyama, M., additional, Nakajima, M., additional, Yazaki, K., additional, Nonaka, M., additional, Sakai, C., additional, Matsumura, S., additional, Numata, T., additional, Yanai, H., additional, Yamamoto, Y., additional, Akatsu, Y., additional, Iijima, H., additional, Masuko, H., additional, Matsuno, Y., additional, Morishima, Y., additional, Endo, T., additional, Saito, T., additional, and Hizawa, N., additional

Published
2021
Full Text
View/download PDF

98. Biological and molecular characterization of linalool-mediated field resistance against Xanthomonas citri subsp. citri in citrus trees

Author

Shimada, T, Endo, T, Fujii, H, Rodríguez, A., Yoshioka, Takehiro, Peña, Leandro, Omura, M, Shimada, T, Endo, T, Fujii, H, Rodríguez, A., Yoshioka, Takehiro, Peña, Leandro, and Omura, M

Abstract

The biological and molecular traits of the Ponkan mandarin (Citrus reticulata Blanco) were characterized in an investigation of the mechanisms of field resistance against citrus canker disease caused by the bacterial pathogen, Xanthomonas citri subsp. citri (Xcc). Various co

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results